zb131
zielbio,spdr s&p biotech,ishares biotechnology
['zb-131', '$ibb', '$xbi', 'zielbio']
zielbio to report interim results of zb-131's first-in-human trial at 2023 asco annual meeting more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt